Zimmer Biomet Holdings, Inc. Share Price London S.E.
Equities
0QQD
US98956P1021
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136.1 CHF | +6.20% | -.--% | -.--% |
31/05 | Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says | MT |
31/05 | Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130 | MT |
Sales 2024 * | 7.76B 7B 647B | Sales 2025 * | 8.12B 7.32B 677B | Capitalization | 23.69B 21.36B 1,976B |
---|---|---|---|---|---|
Net income 2024 * | 986M 889M 82.24B | Net income 2025 * | 1.19B 1.07B 98.93B | EV / Sales 2024 * | 3.61 x |
Net Debt 2024 * | 4.34B 3.91B 362B | Net Debt 2025 * | 3.03B 2.74B 253B | EV / Sales 2025 * | 3.29 x |
P/E ratio 2024 * |
23.6
x | P/E ratio 2025 * |
20.4
x | Employees | - |
Yield 2024 * |
0.84% | Yield 2025 * |
0.85% | Free-Float | 64.77% |
Latest transcript on Zimmer Biomet Holdings, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Ivan Tornos
CEO | Chief Executive Officer | 48 | 01/18/01 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 55 | 01/19/01 |
Nitin Goyal
CTO | Chief Tech/Sci/R&D Officer | - | 07/21/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Higgins
BRD | Director/Board Member | 68 | 01/07/01 |
Betsy Bernard
BRD | Director/Board Member | 68 | 01/09/01 |
Mick Farrell
BRD | Director/Board Member | 51 | 12/14/12 |
Date | Price | Change |
---|---|---|
30/24/30 | - | +-NaN% |
28/24/28 | - | +-NaN% |
24/24/24 | - | +-NaN% |
23/24/23 | - | +-NaN% |
Delayed Quote London S.E., January 29, 2021 at 08:11 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- ZBH Stock
- 0QQD Stock